Deverra Therapeutics

Seattle, United States

Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.

Sep 2024

Equity Crowdfunding

Biotechnology Clinical Trials Medical

Top Investors

5AM VenturesAndy Hill Cancer Research Endowment (CARE) Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Deverra Therapeutics

Who are Deverra Therapeutics's investors?

Deverra Therapeutics's investors include 5AM Ventures, Andy Hill Cancer Research Endowment (CARE) Fund.

Where is Deverra Therapeutics headquartered?

Deverra Therapeutics is headquartered in Seattle, United States.

What does Deverra Therapeutics do?

Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.

What stage is Deverra Therapeutics at?

Deverra Therapeutics is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 4, 2024.

MLA

"Deverra Therapeutics — Funding & Investors." VCBacked, September 4, 2024, https://www.vcbacked.co/company/deverra-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Deverra Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/deverra-therapeutics

Wikipedia (cite web)

{{cite web |title=Deverra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/deverra-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 4, 2024.